Literature DB >> 30989166

A 30-year Trend Analysis in the Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District of Seoul, Korea in 1986-2015.

Sang Hyoung Park1, Ye-Jee Kim2, Kyoung Hoon Rhee3, Young-Ho Kim4, Sung Noh Hong4, Kyung Ho Kim5, Seung In Seo5, Jae Myung Cha6, Sun Yong Park7, Seung Kyu Jeong8, Ji Hyun Lee9, Hyunju Park10, Joo Sung Kim11, Jong Pil Im11, Hyuk Yoon12, Sung Hoon Kim13, Jisun Jang13, Jeong Hwan Kim14, Seong O Suh15, Young Kyun Kim16, Byong Duk Ye1, Suk-Kyun Yang1.   

Abstract

BACKGROUND AND AIMS: Although the incidence of inflammatory bowel disease [IBD] is increasing in Asia, data on long-term epidemiological trends are limited. We performed a 30-year longitudinal study to investigate temporal trends in the epidemiology of Crohn's disease [CD] and ulcerative colitis [UC] in Seoul, Korea.
METHODS: This population-based study included 1431 IBD patients [418 CD, 1013 UC] diagnosed between 1986 and 2015 in the Songpa-Kangdong district of Seoul, Korea. Temporal trends in incidence, prevalence, and disease phenotype at diagnosis were analysed.
RESULTS: The adjusted mean annual incidence rates of CD and UC per 100 000 inhabitants increased from 0.06 (95% confidence interval [CI], 0.05-0.07) and 0.29 [95% CI, 0.27-0.31], respectively, in 1986-1990 to 2.44 [95% CI, 2.38-2.50] and 5.82 [95% CI, 5.73-5.92], respectively, in 2011-2015. Average annual percentage change in IBD incidence was 12.3% in 1986-1995, 12.3% in 1996-2005, and 3.3% in 2006-2015. The male-to-female ratio of the adjusted incidence rate was 3.3:1 for CD and 1.2:1 for UC. Perianal fistula/abscess was present in 43.3% of patients before or at CD diagnosis. At diagnosis, 54.3% of UC patients presented only with proctitis. The adjusted prevalence rate in 2015 was 31.59/100 000 [95% CI, 31.10-32.07] for CD and 76.66/100 000 [95% CI, 75.91-77.42] for UC.
CONCLUSIONS: The incidence and prevalence of IBD in Korea have continued to increase over the past three decades. Korean patients have distinct demographic and phenotypic characteristics, including a male predominance and high frequency of perianal fistula/abscess in CD and high proportion of proctitis in UC.
Copyright © 2019 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Crohn’s disease; SK-IBD Study; incidence; prevalence; ulcerative colitis

Mesh:

Year:  2019        PMID: 30989166     DOI: 10.1093/ecco-jcc/jjz081

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  33 in total

1.  Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease.

Authors:  Mingming Zhu; Xitao Xu; Qi Feng; Zhe Cui; Tianrong Wang; Yunqi Yan; Zhihua Ran
Journal:  Dig Dis Sci       Date:  2020-06-10       Impact factor: 3.199

2.  Inflammatory bowel disease and risk of idiopathic pulmonary fibrosis: A protocol for systematic review and meta-analysis.

Authors:  Jiali Wang; Fushun Kou; Xiao Han; Lei Shi; Rui Shi; Zhibin Wang; Tangyou Mao; Junxiang Li
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

3.  The hospitalization burden of inflammatory bowel disease in China: a nationwide study from 2013 to 2018.

Authors:  Yi-Ming He; Ren Mao; Gang Yuan; Rui-Ming Liang; Jian-Yan Long; Xiao-Qi Ye; Marietta Iacucci; Subrata Ghosh; Shomron Ben-Horin; Gilaad G Kaplan; Yao He; Joseph J Y Sung; Sui Peng; Hai-Bo Wang; Min-Hu Chen
Journal:  Therap Adv Gastroenterol       Date:  2022-06-13       Impact factor: 4.802

4.  Notable gaps between patients' and physicians' perspectives on communication and disease management in Japan: multifaceted ad hoc analyses of the global Ulcerative Colitis Narrative Survey for further optimal care.

Authors:  Kenji Watanabe; Sean Gardiner; Shoko Arai
Journal:  Therap Adv Gastroenterol       Date:  2022-06-14       Impact factor: 4.802

5.  Shift to a Younger Age and Regional Differences in Inflammatory Bowel Disease in Korea: Using Healthcare Administrative Data.

Authors:  Seo-Hee Kim; Yujin Park; Seong Pyo Kim; Sung Hee Lee; Seak Hee Oh; Suk-Kyun Yang; Hyung-Jin Yoon; Kyung Mo Kim
Journal:  Dig Dis Sci       Date:  2022-01-30       Impact factor: 3.487

Review 6.  Crohn's disease.

Authors:  Giulia Roda; Siew Chien Ng; Paulo Gustavo Kotze; Marjorie Argollo; Remo Panaccione; Antonino Spinelli; Arthur Kaser; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Nat Rev Dis Primers       Date:  2020-04-02       Impact factor: 52.329

7.  Is Paradigm for the Role of Balloon-Assisted Enteroscopy Changing in Crohn's Disease?

Authors:  Yoo Jin Lee
Journal:  Gut Liver       Date:  2021-05-15       Impact factor: 4.519

8.  Venous Thromboembolism Risk in Asian Patients with Inflammatory Bowel Disease: A Population-Based Nationwide Inception Cohort Study.

Authors:  Su Young Kim; Yeon Seo Cho; Hyun-Soo Kim; Jung Kuk Lee; Hee Man Kim; Hong Jun Park; Hyunil Kim; Jihoon Kim; Dae Ryong Kang
Journal:  Gut Liver       Date:  2021-11-18       Impact factor: 4.321

9.  Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease.

Authors:  Ji Min Lee; Shu-Chen Wei; Kang-Moon Lee; Byong Duk Ye; Ren Mao; Hyun-Soo Kim; Soo Jung Park; Sang Hyoung Park; Eun Hye Oh; Jong Pil Im; Byung Ik Jang; Dae Bum Kim; Ken Takeuchi
Journal:  Gut Liver       Date:  2022-05-15       Impact factor: 4.321

10.  Proteomic analysis-based discovery of a novel biomarker that differentiates intestinal Behçet's disease from Crohn's disease.

Authors:  Jihye Park; Daeun Jeong; Youn Wook Chung; Jae Hee Cheon; Ji-Hwan Ryu; Seunghan Han; Da Hye Kim; Jongwook Yu
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.